Anal Carcinoma — Trials

Anal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

88 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07217171	A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas	recruiting	Phase 1	160	EvolveImmune United, IncINDUSTRY	1	Sep 15, 2026	clinicaltrials
NCT07602842	A Study of IDP-001 in Advanced or Metastatic Solid Tumors	recruiting	Phase 1 / Phase 2	132	InduPro, Inc.INDUSTRY	1	Sep 3, 2026	clinicaltrials